Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol
  • Published:

Bioengineering mini-colons for ex vivo colorectal cancer research

Abstract

Tumor initiation remains one of the least understood events in cancer biology, largely due to the challenge of dissecting the intricacy of the tumorigenic process in laboratory settings. The insufficient biological complexity of conventional in vitro systems makes animal models the primary experimental approach to study tumorigenesis. Despite providing valuable insights, these in vivo models function as experimental black boxes with limited spatiotemporal resolution of cellular dynamics during oncogenesis. In addition, their use raises ethical concerns, further underscoring the need for alternative ex vivo systems. Here we provide a detailed protocol to integrate state-of-the-art microfabrication, tissue engineering and optogenetic approaches to generate topobiologically complex miniature colons (‘mini-colons’) capable of undergoing tumorigenesis in vitro. We describe the key methodology for the generation of blue light-inducible oncogenic cells, the establishment of hydrogel-based mini-colon scaffolds within microfluidic devices, the development of mini-colons and the induction of spatiotemporally controlled tumorigenesis. This protocol enables the formation and long-term culture of complex cancerous tissues that capture in vivo-like tumoral biology while offering real-time and single-cell resolution analyses. It can be implemented in 4–6 weeks by researchers with prior experience in 3D cell culture techniques. We anticipate that these methodological guidelines will have a broad impact on the cancer research community by opening new avenues for tumorigenesis studies.

Key points

  • This protocol details the generation of topobiologically complex miniature colons capable of undergoing tumorigenesis in vitro. This approach uses key methodologies for the generation of blue light-inducible oncogenic cells, the establishment of hydrogel-based mini-colon scaffolds within microfluidic devices, the development of mini-colons and the induction of spatiotemporally controlled tumorigenesis.

  • The spatiotemporal resolution of cellular dynamics revealed by this approach makes it a versatile in vitro alternative to the animal models.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Protocol overview.
Fig. 2: Generation of light-inducible oncogenic organoids.
Fig. 3: Bioengineering of mini-colon hydrogel scaffolds.
Fig. 4: Morphogenesis of light-inducible mini-colons.
Fig. 5: Spatiotemporally controlled ex vivo tumorigenesis.
Fig. 6: Applications and downstream processing of mini-colons.

Similar content being viewed by others

Data availability

The laser ablation template used for the generation of hydrogel mini-colon scaffolds is available at GitHub (https://github.com/LorenzoLF/Mini-colon_bioengineering) and Zenodo35. All other relevant data can be accessed through the original publication describing the development of mini-colons for tumorigenic studies7.

References

  1. Kapałczyńska, M. et al. 2D and 3D cell cultures—a comparison of different types of cancer cell cultures. Arch. Med. Sci. 14, 910–919 (2018).

    PubMed  Google Scholar 

  2. Herms, A. et al. Self-sustaining long-term 3D epithelioid cultures reveal drivers of clonal expansion in esophageal epithelium. Nat. Genet. 56, 2158–2173 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lorenzo-Martín, L. F. et al. VAV2 signaling promotes regenerative proliferation in both cutaneous and head and neck squamous cell carcinoma. Nat. Commun. 11, 4788 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kim, J., Koo, B. K. & Knoblich, J. A. Human organoids: model systems for human biology and medicine. Nat. Rev. Mol. Cell Biol. 21, 571–584 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Drost, J. & Clevers, H. Organoids in cancer research. Nat. Rev. Cancer 18, 407–418 (2018).

    Article  CAS  PubMed  Google Scholar 

  6. O’Rourke, K. P. et al. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer. Nat. Biotechnol. 35, 577–582 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lorenzo-Martín, L. F. et al. Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo. Nature 629, 450–457 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Nikolaev, M. et al. Homeostatic mini-intestines through scaffold-guided organoid morphogenesis. Nature 585, 574–578 (2020).

    Article  PubMed  Google Scholar 

  9. Lorenzo-Martín, L. F. et al. Patient-derived mini-colons enable long-term modeling of tumor-microenvironment complexity. Nat. Biotechnol. 43, 727–736 (2025).

    Article  PubMed  Google Scholar 

  10. Mitrofanova, O. et al. Bioengineered human colon organoids with in vivo-like cellular complexity and function. Cell Stem Cell 31, 1175–1186.e1177 (2024).

    Article  CAS  PubMed  Google Scholar 

  11. Shih, C., Shilo, B. Z., Goldfarb, M. P., Dannenberg, A. & Weinberg, R. A. Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc. Natl Acad. Sci. USA 76, 5714–5718 (1979).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Thorne, C. A. et al. Enteroid monolayers reveal an autonomous WNT and BMP circuit controlling intestinal epithelial growth and organization. Dev. Cell 44, 624–633.e624 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Krotenberg Garcia, A. et al. Active elimination of intestinal cells drives oncogenic growth in organoids. Cell Rep. 36, 109307 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Weiswald, L. B. et al. A short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation. Br. J. Cancer 108, 1720–1731 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Lo, Y. H., Karlsson, K. & Kuo, C. J. Applications of organoids for cancer biology and precision medicine. Nat. Cancer 1, 761–773 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  16. van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933–945 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  17. Carvalho, M. R. et al. Colorectal tumor-on-a-chip system: a 3D tool for precision onco-nanomedicine. Sci. Adv. 5, eaaw1317 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Brassard, J. A., Nikolaev, M., Hübscher, T., Hofer, M. & Lutolf, M. P. Recapitulating macro-scale tissue self-organization through organoid bioprinting. Nat. Mater. 20, 22–29 (2021).

    Article  CAS  PubMed  Google Scholar 

  19. Sun, H. et al. Prediction of clinical precision chemotherapy by patient-derived 3D bioprinting models of colorectal cancer and its liver metastases. Adv. Sci. 11, e2304460 (2024).

    Article  Google Scholar 

  20. Shin, W. & Kim, H. J. 3D in vitro morphogenesis of human intestinal epithelium in a gut-on-a-chip or a hybrid chip with a cell culture insert. Nat. Protoc. 17, 910–939 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Costello, C. M. et al. Microscale bioreactors for in situ characterization of GI epithelial cell physiology. Sci. Rep. 7, 12515 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  22. Costello, C. M. et al. 3-D intestinal scaffolds for evaluating the therapeutic potential of probiotics. Mol. Pharm. 11, 2030–2039 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Samsa, L. A., Williamson, I. A. & Magness, S. T. Quantitative analysis of intestinal stem cell dynamics using microfabricated cell culture arrays. Methods Mol. Biol. 1842, 139–166 (2018).

    Article  CAS  PubMed  Google Scholar 

  24. Jalili-Firoozinezhad, S. et al. A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip. Nat. Biomed. Eng. 3, 520–531 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Cho, K. R. & Vogelstein, B. Genetic alterations in the adenoma–carcinoma sequence. Cancer 70, 1727–1731 (1992).

    Article  CAS  PubMed  Google Scholar 

  26. Meador, K. et al. Achieving tight control of a photoactivatable Cre recombinase gene switch: new design strategies and functional characterization in mammalian cells and rodent. Nucleic Acids Res. 47, e97 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  27. Kawano, F., Okazaki, R., Yazawa, M. & Sato, M. A photoactivatable Cre-loxP recombination system for optogenetic genome engineering. Nat. Chem. Biol. 12, 1059–1064 (2016).

    Article  CAS  PubMed  Google Scholar 

  28. Duplus-Bottin, H. et al. A single-chain and fast-responding light-inducible Cre recombinase as a novel optogenetic switch. eLife https://doi.org/10.7554/eLife.61268 (2021).

  29. Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262–265 (2009).

    Article  CAS  PubMed  Google Scholar 

  30. Drost, J. et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature 521, 43–47 (2015).

    Article  CAS  PubMed  Google Scholar 

  31. Louis, P., Hold, G. L. & Flint, H. J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661–672 (2014).

    Article  CAS  PubMed  Google Scholar 

  32. Bernstein, C. et al. Carcinogenicity of deoxycholate, a secondary bile acid. Arch. Toxicol. 85, 863–871 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Wu, X. et al. Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer. J. Cancer 9, 2510–2517 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  34. Dmitrieva-Posocco, O. et al. β-Hydroxybutyrate suppresses colorectal cancer. Nature 605, 160–165 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Lorenzo-Martín, L. F., Hübscher, T., Langer, J., Nikolaev, M. & Lutolf, M. P. Mini-colon_bioengineering. Zenodo https://doi.org/10.5281/zenodo.17120748 (2025).

  36. Wong, C. C. & Yu, J. Gut microbiota in colorectal cancer development and therapy. Nat. Rev. Clin. Oncol. 20, 429–452 (2023).

    Article  PubMed  Google Scholar 

  37. Castejón, M. et al. Energy restriction and colorectal cancer: a call for additional research. Nutrients https://doi.org/10.3390/nu12010114 (2020).

Download references

Acknowledgements

We thank A. Bowler and F. Radtke for the inducible A, AK and AKP mouse colon organoids; M. Thomson for the original light-inducible plasmids; M. Wernig and G. Neumayer for the initial idea and work on the doxycycline- and light-inducible system; A. Aebi and B. Schneider for lentivirus production; C. Baur for discussing, designing and building the custom illumination device; A. Chrisnandy for assistance on photomask fabrication; O. Mitrofanova, B. Elçi and Y. Tinguely for assistance on microfluidic device fabrication; L. Tillard for technical support; and J. Prébandier for administrative assistance. We acknowledge support from the following EPFL core facilities: CMi, CPG, PTBTG, HCF, BIOP, FCCF, BSF and GECF.

Author information

Authors and Affiliations

Authors

Contributions

L.F.L.-M. conceived the study, designed experiments, carried out the experimental work, analyzed the data, performed artwork design and wrote the manuscript. T.H. generated the OptoCre module and blue light-associated systems, performed experimental work and analyzed data. J.L. produced the microfluidic devices and optimized hydrogel scaffolds. M.N. designed and developed the first mini-gut system. M.P.L. conceived the work, designed experiments and edited the manuscript.

Corresponding authors

Correspondence to L. Francisco Lorenzo-Martín or Matthias P. Lutolf.

Ethics declarations

Competing interests

The EPFL has filed for patent protection (nos. EP16199677.2, PCT/EP2017/079651, US20190367872A1) on the scaffold-guided organoid technology used here, and M.P.L. and M.N. are named as inventors on those patents. M.P.L. and M.N. are employees of Roche. The other authors declare no competing interests.

Peer review

Peer review information

Nature Protocols thanks Mehdi Nikkhah, Xiling Shen and Yuan Wang for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key references

Nikolaev, M. et al. Nature 585, 574–578 (2020): https://doi.org/10.1038/s41586-020-2724-8

Lorenzo-Martín, L. F. et al. Nature 629, 450–457 (2024): https://doi.org/10.1038/s41586-024-07330-2

Lorenzo-Martín, L. F. et al. Nat. Biotechnol. 43, 727–736 (2025): https://doi.org/10.1038/s41587-024-02301-4

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lorenzo-Martín, L.F., Hübscher, T., Langer, J. et al. Bioengineering mini-colons for ex vivo colorectal cancer research. Nat Protoc (2025). https://doi.org/10.1038/s41596-025-01292-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s41596-025-01292-z

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer